| Gene ID | 3559 |
| Symbol | IL2RA |
| Synonymous | CD25|IDDM10|IL2R|TCGFR|p55 |
| Full name | interleukin 2 receptor, alpha |
| Gene description | IL-2 receptor subunit alpha|IL-2R subunit alpha|TAC antigen|interleukin-2 receptor subunit alpha |
| Cytoband | 10p15-p14 |
| Gene type | protein-coding |
| Synonymous | MIM:147730; HGNC:HGNC:6008; Ensembl:ENSG00000134460; HPRD:00986; Vega:OTTHUMG00000017616 |
Pathways and Diseases | Detail |
|---|---|
Pathway | IL2 signaling events mediated by STAT5;PID Curated;200158 |
Pathway | Jak-STAT signaling pathway;KEGG PATHWAY;hsa04630 |
Pathway | Signaling in Immune system;Reactome;REACT:6900 |
Pathway | IL12 signaling mediated by STAT4;PID Curated;200197 |
Pathway | Calcium signaling in the CD4+ TCR pathway;PID Curated;200159 |
Pathway | il-2 receptor beta chain in t cell activation;PID BioCarta;100129 |
Pathway | Cytokine-cytokine receptor interaction;KEGG PATHWAY;hsa04060 |
Pathway | Arf6 trafficking events;PID Curated;200046 |
Pathway | Downstream signaling in naive CD8+ T cells;PID Curated;200184 |
Pathway | Endocytosis;KEGG PATHWAY;hsa04144 |
Pathway | Hematopoietic cell lineage;KEGG PATHWAY;hsa04640 |
Pathway | IL2 signaling events mediated by PI3K;PID Curated;200099 |
Pathway | IL2-mediated signaling events;PID Curated;200082 |
Pathway | Interleukin signaling pathway;PANTHER;P00036 |
Pathway | IL12-mediated signaling events;PID Curated;200034 |
Pathway | il 2 signaling pathway;PID BioCarta;100130 |
Pathway | Calcineurin-regulated NFAT-dependent transcription in lymphocytes;PID Curated;200039 |
Disease | Lupus erythematosus;FunDO |
Disease | Type 1 diabetes;NHGRI |
Disease | Graves' disease;GAD |
Disease | T-B+ Severe combined immunodeficiencies;KEGG DISEASE;H00091 |
Disease | Lung cancer;FunDO |
Disease | Periodontitis;FunDO |
Disease | Down syndrome;FunDO |
Disease | HIV infection;FunDO |
Disease | Alopecia areata;NHGRI |
Disease | Liver cancer;FunDO |
Disease | Mitral valve disease;FunDO |
Disease | Embryoma;FunDO |
Disease | Pancreatitis;FunDO |
Disease | Multiple sclerosis;NHGRI |
Disease | IMMUNE;GAD |
Disease | Leukemia;FunDO |
Disease | HIV;GAD |
Disease | Systemic infection;FunDO |
Disease | Pancreas cancer;FunDO |
Disease | INFECTION;GAD |
Disease | Eosinophilia;FunDO |
Disease | Autoimmune disease;FunDO |
Disease | Diabetes;KEGG DISEASE |
Disease | Tuberculosis;FunDO |
Disease | diabetes, type 1;GAD |
Disease | Interleukin-2 receptor, alpha chain, deficiency of;OMIM |
Disease | Rheumatoid arthritis;NHGRI |
Disease | Squamous cell cancer;FunDO |
Disease | Primary immunodeficiency;KEGG DISEASE |
Disease | Breast cancer;FunDO |
Disease | Hemolytic-Uremic syndrome;FunDO |
Disease | Metabolic diseases;KEGG DISEASE |
Disease | type 1 diabetes;GAD |
Disease | Type I diabetes mellitus;KEGG DISEASE;H00408 |
Disease | Vitiligo;NHGRI |
Disease | Immune system diseases;KEGG DISEASE |
Disease | Lymphoma;FunDO |
Disease | multiple sclerosis;GAD |
Disease | Diabetes, mellitus, insulin-dependent, susceptibility to, 10;OMIM |
Sequence Information | |
|---|---|
Nucleotide Sequence | >3559 : length: 3216 GGCAGTTTCCTGGCTGAACACGCCAGCCCAATACTTAAAGAGAGCAACTCCTGACTCCGATAGAGACTGGATGGACCCACAAGGGTGACAGCCCAGGCGGACCGATCTTCCCATCCCACA TCCTCCGGCGCGATGCCAAAAAGAGGCTGACGGCAACTGGGCCTTCTGCAGAGAAAGACCTCCGCTTCACTGCCCCGGCTGGTCCCAAGGGTCAGGAAGATGGATTCATACCTGCTGATG TGGGGACTGCTCACGTTCATCATGGTGCCTGGCTGCCAGGCAGAGCTCTGTGACGATGACCCGCCAGAGATCCCACACGCCACATTCAAAGCCATGGCCTACAAGGAAGGAACCATGTTG AACTGTGAATGCAAGAGAGGTTTCCGCAGAATAAAAAGCGGGTCACTCTATATGCTCTGTACAGGAAACTCTAGCCACTCGTCCTGGGACAACCAATGTCAATGCACAAGCTCTGCCACT CGGAACACAACGAAACAAGTGACACCTCAACCTGAAGAACAGAAAGAAAGGAAAACCACAGAAATGCAAAGTCCAATGCAGCCAGTGGACCAAGCGAGCCTTCCAGGTCACTGCAGGGAA CCTCCACCATGGGAAAATGAAGCCACAGAGAGAATTTATCATTTCGTGGTGGGGCAGATGGTTTATTATCAGTGCGTCCAGGGATACAGGGCTCTACACAGAGGTCCTGCTGAGAGCGTC TGCAAAATGACCCACGGGAAGACAAGGTGGACCCAGCCCCAGCTCATATGCACAGGTGAAATGGAGACCAGTCAGTTTCCAGGTGAAGAGAAGCCTCAGGCAAGCCCCGAAGGCCGTCCT GAGAGTGAGACTTCCTGCCTCGTCACAACAACAGATTTTCAAATACAGACAGAAATGGCTGCAACCATGGAGACGTCCATATTTACAACAGAGTACCAGGTAGCAGTGGCCGGCTGTGTT TTCCTGCTGATCAGCGTCCTCCTCCTGAGTGGGCTCACCTGGCAGCGGAGACAGAGGAAGAGTAGAAGAACAATCTAGAAAACCAAAAGAACAAGAATTTCTTGGTAAGAAGCCGGGAAC AGACAACAGAAGTCATGAAGCCCAAGTGAAATCAAAGGTGCTAAATGGTCGCCCAGGAGACATCCGTTGTGCTTGCCTGCGTTTTGGAAGCTCTGAAGTCACATCACAGGACACGGGGCA GTGGCAACCTTGTCTCTATGCCAGCTCAGTCCCATCAGAGAGCGAGCGCTACCCACTTCTAAATAGCAATTTCGCCGTTGAAGAGGAAGGGCAAAACCACTAGAACTCTCCATCTTATTT TCATGTATATGTGTTCATTAAAGCATGAATGGTATGGAACTCTCTCCACCCTATATGTAGTATAAAGAAAAGTAGGTTTACATTCATCTCATTCCAACTTCCCAGTTCAGGAGTCCCAAG GAAAGCCCCAGCACTAACGTAAATACACAACACACACACTCTACCCTATACAACTGGACATTGTCTGCGTGGTTCCTTTCTCAGCCGCTTCTGACTGCTGATTCTCCCGTTCACGTTGCC TAATAAACATCCTTCAAGAACTCTGGGCTGCTACCCAGAAATCATTTTACCCTTGGCTCAATCCTCTAAGCTAACCCCCTTCTACTGAGCCTTCAGTCTTGAATTTCTAAAAAACAGAGG CCATGGCAGAATAATCTTTGGGTAACTTCAAAACGGGGCAGCCAAACCCATGAGGCAATGTCAGGAACAGAAGGATGAATGAGGTCCCAGGCAGAGAATCATACTTAGCAAAGTTTTACC TGTGCGTTACTAATTGGCCTCTTTAAGAGTTAGTTTCTTTGGGATTGCTATGAATGATACCCTGAATTTGGCCTGCACTAATTTGATGTTTACAGGTGGACACACAAGGTGCAAATCAAT GCGTACGTTTCCTGAGAAGTGTCTAAAAACACCAAAAAGGGATCCGTACATTCAATGTTTATGCAAGGAAGGAAAGAAAGAAGGAAGTGAAGAGGGAGAAGGGATGGAGGTCACACTGGT AGAACGTAACCACGGAAAAGAGCGCATCAGGCCTGGCACGGTGGCTCAGGCCTATAACCCCAGCTCCCTAGGAGACCAAGGCGGGAGCATCTCTTGAGGCCAGGAGTTTGAGACCAGCCT GGGCAGCATAGCAAGACACATCCCTACAAAAAATTAGAAATTGGCTGGATGTGGTGGCATACGCCTGTAGTCCTAGCCACTCAGGAGGCTGAGGCAGGAGGATTGCTTGAGCCCAGGAGT TCGAGGCTGCAGTCAGTCATGATGGCACCACTGCACTCCAGCCTGGGCAACAGAGCAAGATCCTGTCTTTAAGGAAAAAAAGACAAGATGAGCATACCAGCAGTCCTTGAACATTATCAA AAAGTTCAGCATATTAGAATCACCGGGAGGCCTTGTTAAAAGAGTTCGCTGGGCCCATCTTCAGAGTCTCTGAGTTGTTGGTCTGGAATAGAGCCAAATGTTTTGTGTGTCTAACAATTC CCAGGTGCTGTTGCTGCTGCTACTATTCCAGGAACACACTTTGAGAACCATTGTGTTATTGCTCTGCACGCCCACCCACTCTCAACTCCCACGAAAAAAATCAACTTCCAGAGCTAAGAT TTCGGTGGAAGTCCTGGTTCCATATCTGGTGCAAGATCTCCCCTCACGAATCAGTTGAGTCAACATTCTAGCTCAACAACATCACACGATTAACATTAACGAAAATTATTCATTTGGGAA ACTATCAGCCAGTTTTCACTTCTGAAGGGGCAGGAGAGTGTTATGAGAAATCACGGCAGTTTTCAGCAGGGTCCAGATTCAGATTAAATAACTATTTTCTGTCATTTCTGTGACCAACCA CATACAAACAGACTCATCTGTGCACTCTCCCCCTCCCCCTTCAGGTATATGTTTTCTGAGTAAAGTTGAAAAGAATCTCAGACCAGAAAATATAGATATATATTTAAATCTTACTTGAGT AGAACTGATTACGACTTTTGGGTGTTGAGGGGTCTATAAGATCAAAACTTTTCCATGATAATACTAAGATGTTATCGACCATTTATCTGTCCTTCTCTCAAAAGTGTATGGTGGAATTTT CCAGAAGCTATGTGATACGTGATGATGTCATCACTCTGCTGTTAACATATAATAAATTTATTGCTATTGTTTATAAAAGAATAAATGATATTTTTT |
Protein Sequence | >3559 : length: 272 MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKSGSLYMLCTGNSSHSSWDNQCQCTSSATRNTTKQVTPQPEEQKERKTTEMQSPMQPVDQAS LPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALHRGPAESVCKMTHGKTRWTQPQLICTGEMETSQFPGEEKPQASPEGRPESETSCLVTTTDFQIQTEMAATMETSIFTTEYQ VAVAGCVFLLISVLLLSGLTWQRRQRKSRRTI |